Point of Care Infectious Disease Testing Market Size, Share & Trends Report

Point of Care Infectious Disease Testing Market Size, Share & Trends Analysis Report By Disease (HIV POC, HBV POC, Influenza/Flu POC, TB & drug-resistant TB POC), By End-use, And Segment Forecasts, 2018 - 2025

  • Report ID: GVR-1-68038-569-4
  • Number of Pages: 145
  • Format: Electronic (PDF)
  • Historical Range: 2014 - 2016
  • Industry: Healthcare

Market Segmentation

  • Point of Care Infectious Disease Testing Disease Outlook (Revenue, USD Million, 2014 - 2025)
    • HIV POC
    • Clostridium difficile POC
    • HBV POC
    • Pneumonia or Streptococcus associated infections
    • Respiratory syncytial virus (RSV) POC
    • HPV POC
    • Influenza/Flu POC
    • HCV POC
    • MRSA POC
    • TB and drug-resistant TB POC
    • HSV (Herpes Simplex Virus) POC
    • Other infectious disease POC
  • Point of Care Infectious Disease Testing End-Use Outlook (Revenue, USD Million, 2014 - 2025)
    • Hospitals
    • Clinics
    • Home
    • Assisted Living Healthcare Facilities
    • Laboratories
    • Others
  • Point of Care Infectious Disease Testing Regional Outlook (Revenue, USD Million, 2014 - 2025)
    • North America
      • North America Disease Outlook (Revenue, USD Million, 2014 - 2025)
        • HIV POC
        • Clostridium difficile POC
        • HBV POC
        • Pneumonia or Streptococcus associated infections
        • Respiratory syncytial virus (RSV) POC
        • HPV POC
        • Influenza/Flu POC
        • HCV POC
        • MRSA POC
        • TB and drug-resistant TB POC
        • HSV (Herpes Simplex Virus) POC
        • Other infectious disease POC
      • North America End-use Outlook (Revenue, USD Million, 2014 - 2025)
        • Hospitals
        • Clinics
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
        • Others
      • The U.S.
        • The U.S. Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • The U.S. End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
      • Canada
        • Canada Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • Canada End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
    • Europe
      • Europe Disease Outlook (Revenue, USD Million, 2014 - 2025)
        • HIV POC
        • Clostridium difficile POC
        • HBV POC
        • Pneumonia or Streptococcus associated infections
        • Respiratory syncytial virus (RSV) POC
        • HPV POC
        • Influenza/Flu POC
        • HCV POC
        • MRSA POC
        • TB and drug-resistant TB POC
        • HSV (Herpes Simplex Virus) POC
        • Other infectious disease POC
      • Europe End-use Outlook (Revenue, USD Million, 2014 - 2025)
        • Hospitals
        • Clinics
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
        • Others
      • Germany
        • Germany Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • Germany End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
      • The U.K.
        • The U.K. Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • The U.K. End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
    • Asia Pacific
      • Asia Pacific Disease Outlook (Revenue, USD Million, 2014 - 2025)
        • HIV POC
        • Clostridium difficile POC
        • HBV POC
        • Pneumonia or Streptococcus associated infections
        • Respiratory syncytial virus (RSV) POC
        • HPV POC
        • Influenza/Flu POC
        • HCV POC
        • MRSA POC
        • TB and drug-resistant TB POC
        • HSV (Herpes Simplex Virus) POC
        • Other infectious disease POC
      • Asia Pacific End-use Outlook (Revenue, USD Million, 2014 - 2025)
        • Hospitals
        • Clinics
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
        • Others
      • Japan
        • Japan Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • Japan End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
      • China
        • China Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • China End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
    • Latin America
      • Latin America Disease Outlook (Revenue, USD Million, 2014 - 2025)
        • HIV POC
        • Clostridium difficile POC
        • HBV POC
        • Pneumonia or Streptococcus associated infections
        • Respiratory syncytial virus (RSV) POC
        • HPV POC
        • Influenza/Flu POC
        • HCV POC
        • MRSA POC
        • TB and drug-resistant TB POC
        • HSV (Herpes Simplex Virus) POC
        • Other infectious disease POC
      • Latin America End-use Outlook (Revenue, USD Million, 2014 - 2025)
        • Hospitals
        • Clinics
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
        • Others
      • Brazil
        • Brazil Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • Brazil End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others
    • MEA
      • MEA Disease Outlook (Revenue, USD Million, 2014 - 2025)
        • HIV POC
        • Clostridium difficile POC
        • HBV POC
        • Pneumonia or Streptococcus associated infections
        • Respiratory syncytial virus (RSV) POC
        • HPV POC
        • Influenza/Flu POC
        • HCV POC
        • MRSA POC
        • TB and drug-resistant TB POC
        • HSV (Herpes Simplex Virus) POC
        • Other infectious disease POC
      • MEA End-use Outlook (Revenue, USD Million, 2014 - 2025)
        • Hospitals
        • Clinics
        • Home
        • Assisted Living Healthcare Facilities
        • Laboratories
        • Others
      • South Africa
        • South Africa Disease Outlook (Revenue, USD Million, 2014 - 2025)
          • HIV POC
          • Clostridium difficile POC
          • HBV POC
          • Pneumonia or Streptococcus associated infections
          • Respiratory syncytial virus (RSV) POC
          • HPV POC
          • Influenza/Flu POC
          • HCV POC
          • MRSA POC
          • TB and drug-resistant TB POC
          • HSV (Herpes Simplex Virus) POC
          • Other infectious disease POC
        • South Africa End-use Outlook (Revenue, USD Million, 2014 - 2025)
          • Hospitals
          • Clinics
          • Home
          • Assisted Living Healthcare Facilities
          • Laboratories
          • Others

Report content

Qualitative Analysis

  • Industry overview
  • Industry trends
  • Market drivers and restraints
  • Market size
  • Growth prospects
  • Porter’s analysis
  • PESTEL analysis
  • Key market opportunities prioritized
  • Competitive landscape
    • Company overview
    • Financial performance
    • Product benchmarking
    • Latest strategic developments

Quantitative Analysis

  • Market size, estimates, and forecast from 2014 to 2025
  • Market estimates and forecast for product segments up to 2025
  • Regional market size and forecast for product segments up to 2025
  • Market estimates and forecast for application segments up to 2025
  • Regional market size and forecast for application segments up to 2025
  • Company financial performance
What questions do you have? Get quick response from our industry experts. Request a Free Consultation
pdf

GET A FREE SAMPLE

bck

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

cog

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

BBB icon gvr sidebar D&B icon gvr sidebar

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.